A novel point-of-care oral anti-HCV assay: Is it reliable for screening hepatitis C virus infection in the era of direct-acting antivirals?

Recent advance in the direct-acting antivirals (DAAs) offers the potentials to eradicate hepatitis C virus (HCV) worldwide and makes universal screening more urgent. A point-of-care (POC) oral anti-HCV assay, the Fortune assay, was developed and its performance was evaluated. Individuals with or wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Rui-Feng, Liu, Yan, Zhao, Cai-Yan, Ding, Ya-Xing, Chen, Yu, Wang, Ya-Dong, Duan, Zhong-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372169/
https://www.ncbi.nlm.nih.gov/pubmed/30753207
http://dx.doi.org/10.1371/journal.pone.0211795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372169/
https://www.ncbi.nlm.nih.gov/pubmed/30753207
http://dx.doi.org/10.1371/journal.pone.0211795

Ejemplares similares